1. Martikainen J, Rajaniemi S. Drug reimbursement systems in EU member states, Iceland and Norway. Helsinki: The Social Insurance Institution, Finland, Social security and health reports 54; 2002.
2. Booz&Co. The value of OTC medicines to the United States. 2012.
http://www.yourhealthathand.org/images/uploads/The_Value_of_OTC_Medicine_to_the_United_States_BoozCo.pdf
. Accessed 29 Nov 2016.
3. Macquarie University. The value of OTC medicines in Australia. 2014.
http://www.wsmi.org/wp-content/data/pdf/FINALWEBCOPYASMI_ValueStudy.pdf
. Accessed 29 Nov 2016.
4. Ferreira CN, Santana CF, Rufino CS. The value of OTC medicines in Brazilian public health systems (SUS). Pfizer Brasil, Sao Paulo, Brazil (elsevier). 2015.
http://www.valueinhealthjournal.com/article/S1098-3015%2815%2900569-0/pdf
. Accessed 29 Nov 2016.
5. Italia S, Brand H, Heinrich J, Berdel D, von Berg A, Wolfenstetter SB. Utilization of self-medication and prescription drugs among 15-year-old children from the German GINIplus birth cohort. Pharmacoepidemiol Drug Saf. 2015;24:1133–44.
10.1002/pds.3829
.